Characteristics of Japanese physician influencers on Twitter during the COVID-19 pandemic and fact-checking their tweets on COVID-19-related drugs.

COVID-19 Medical Informatics SARS-CoV-2 Social Media Social Networking Service

Journal

Postgraduate medical journal
ISSN: 1469-0756
Titre abrégé: Postgrad Med J
Pays: England
ID NLM: 0234135

Informations de publication

Date de publication:
15 Nov 2023
Historique:
received: 09 03 2023
revised: 19 08 2023
accepted: 21 09 2023
medline: 16 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: aheadofprint

Résumé

During the coronavirus disease-2019 (COVID-19) pandemic, segments of the public relied on social media platforms such as Twitter for medical information shared by medical personnel. Although physicians are likely to disseminate more accurate information on Twitter than non-medical individuals, it cannot be taken for granted. As such, tweets written by physicians in Japan should also be scrutinized for accuracy. The purpose of this study was to create a profile of the most popular physician influencers on Twitter in Japan, and to do a fact-check of their tweets regarding COVID-19-related drugs. This is a retrospective observational study. We purchased Twitter data for Japan for the initial 9 months of the COVID-19 pandemic (from January 2020 to September 2020), and extracted tweets with keywords related to COVID-19 at a sampling rate of 3%. The most popular physicians were identified and selected consecutively by searching for the top 1000 accounts using Twitter's search function. These top accounts were considered influencers and their tweets and retweets concerning COVID-19-related drugs were fact-checked against scientific literature. We identified 21 physician influencers with real names: most were male in their 40s and 50s working at private medical facilities. The contents of their tweets were mainly sourced from scientific publications that were current at that time. The fact-check revealed that only one of 50 tweets was not correct while the others had no identifiable inaccuracies. Except for one tweet, tweets written and retweeted by Japanese physician influencers concerning the COVID-19-related drugs contained predominantly accurate information.

Sections du résumé

BACKGROUND BACKGROUND
During the coronavirus disease-2019 (COVID-19) pandemic, segments of the public relied on social media platforms such as Twitter for medical information shared by medical personnel. Although physicians are likely to disseminate more accurate information on Twitter than non-medical individuals, it cannot be taken for granted. As such, tweets written by physicians in Japan should also be scrutinized for accuracy.
PURPOSE OBJECTIVE
The purpose of this study was to create a profile of the most popular physician influencers on Twitter in Japan, and to do a fact-check of their tweets regarding COVID-19-related drugs.
DESIGN METHODS
This is a retrospective observational study.
METHODS METHODS
We purchased Twitter data for Japan for the initial 9 months of the COVID-19 pandemic (from January 2020 to September 2020), and extracted tweets with keywords related to COVID-19 at a sampling rate of 3%. The most popular physicians were identified and selected consecutively by searching for the top 1000 accounts using Twitter's search function. These top accounts were considered influencers and their tweets and retweets concerning COVID-19-related drugs were fact-checked against scientific literature.
RESULTS RESULTS
We identified 21 physician influencers with real names: most were male in their 40s and 50s working at private medical facilities. The contents of their tweets were mainly sourced from scientific publications that were current at that time. The fact-check revealed that only one of 50 tweets was not correct while the others had no identifiable inaccuracies.
CONCLUSIONS CONCLUSIONS
Except for one tweet, tweets written and retweeted by Japanese physician influencers concerning the COVID-19-related drugs contained predominantly accurate information.

Identifiants

pubmed: 37968828
pii: 7423906
doi: 10.1093/postmj/qgad098
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of the Environment, Japan

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Fellowship of Postgraduate Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Tomoya Suzuki (T)

Medical Governance Research Institute, Minato, Tokyo 108-0074, Japan.
School of Medicine, Akita University, Akita 010-8543, Japan.

Tetsuya Tanimoto (T)

Medical Governance Research Institute, Minato, Tokyo 108-0074, Japan.
Department of Internal Medicine, Navitas Clinic, Tachikawa, Tokyo 190-0023, Japan.

Sae Kamamoto (S)

Medical Governance Research Institute, Minato, Tokyo 108-0074, Japan.
Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3125, Japan.

Akihiko Ozaki (A)

Medical Governance Research Institute, Minato, Tokyo 108-0074, Japan.
Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima 972-8322, Japan.

Hiroyuki A Torii (HA)

School of Science, The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan.

Daisuke Hase (D)

School of Engineering, The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan.

Anju Murayama (A)

Tohoku University School of Medicine, Sendai, Miyagi 980-8575, Japan.

Hiroki Yoshimura (H)

Medical Governance Research Institute, Minato, Tokyo 108-0074, Japan.
School of Medicine, Hiroshima University, Hiroshima 734-8553, Japan.

Kazuko Uno (K)

Louis Pasteur Center for Medical Research, Sakyo, Kyoto 606-8225, Japan.

Classifications MeSH